T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPE
1601
DELISTED
Callon Petroleum Company
CPE
| $2.08M | ﹤0.01% |
17,371
+31
| +0.2% | +$3.46K |
|
|
GMS
1602
DELISTED
GMS Inc
GMS
| $2.08M | ﹤0.01% |
89,588
-834,722
| -90% | -$21.2M |
|
|
NUAN
1603
DELISTED
Nuance Communications, Inc.
NUAN
| $2.07M | ﹤0.01% |
138,126
+872
| +0.6% | +$12.1K |
|
|
SC
1604
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.06M | ﹤0.01% |
102,851
-287,993
| -74% | -$5.91M |
|
1605
Healthcare Realty
HR
$6.58B
| $2.05M | ﹤0.01% |
76,972
+1,467
| +2% | +$40.4K |
|
|
XHR
1606
Xenia Hotels & Resorts
XHR
$1.76B
| $2.05M | ﹤0.01% |
86,534
+119
| +0.1% | +$2.87K |
|
1607
SM Energy
SM
$7.71B
| $2.05M | ﹤0.01% |
64,899
-165
| -0.3% | -$4.74K |
|
|
OLBK
1608
DELISTED
Old Line Bancshares, Inc.
OLBK
| $2.04M | ﹤0.01% |
64,609
-117,708
| -65% | -$4.03M |
|
|
HRC
1609
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.04M | ﹤0.01% |
21,621
+203
| +0.9% | +$19.1K |
|
|
NOAH
1610
Noah Holdings
NOAH
$591M
| $2.04M | ﹤0.01% |
48,372
-36,792
| -43% | -$1.68M |
|
|
BLD
1611
DELISTED
TopBuild
BLD
| $2.04M | ﹤0.01% |
35,808
+12,010
| +50% | +$855K |
|
|
SGMO
1612
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.03M | ﹤0.01% |
119,793
-802
| -0.7% | -$12.2K |
|
1613
Associated Banc-Corp
ASB
$6.07B
| $2.02M | ﹤0.01% |
77,898
+145
| +0.2% | +$3.96K |
|
1614
Omega Healthcare
OHI
$13.9B
| $2.02M | ﹤0.01% |
61,619
-6,606
| -10% | -$210K |
|
1615
American States Water
AWR
$3.52B
| $2.01M | ﹤0.01% |
32,824
-78
| -0.2% | -$4.68K |
|
|
DHC
1616
Diversified Healthcare Trust
DHC
$2.03B
| $2M | ﹤0.01% |
114,080
+992
| +0.9% | +$18.2K |
|
1617
OraSure Technologies
OSUR
$277M
| $2M | ﹤0.01% |
129,577
-545
| -0.4% | -$8.93K |
|
|
MDR
1618
DELISTED
McDermott International
MDR
| $2M | ﹤0.01% |
108,337
+5,000
| +5% | +$93.5K |
|
1619
CoreCivic
CXW
$3.13B
| $2M | ﹤0.01% |
82,050
-188
| -0.2% | -$4.7K |
|
1620
Aecom
ACM
$8.19B
| $1.99M | ﹤0.01% |
61,000
+99
| +0.2% | +$3.26K |
|
1621
First Solar
FSLR
$24B
| $1.98M | ﹤0.01% |
40,940
-16
| -0% | -$830 |
|
1622
Core Laboratories
CLB
$569M
| $1.97M | ﹤0.01% |
16,980
-153,219
| -90% | -$17.3M |
|
1623
AMN Healthcare
AMN
$1.34B
| $1.96M | ﹤0.01% |
35,806
+4,280
| +14% | +$245K |
|
|
UNT
1624
DELISTED
UNIT Corporation
UNT
| $1.95M | ﹤0.01% |
74,915
+4,515
| +6% | +$117K |
|
1625
Credit Acceptance
CACC
$6.05B
| $1.95M | ﹤0.01% |
4,454
+57
| +1% | +$23.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.